HCPCS Level II · Drugs administered other than oral method
J0491Injection, anifrolumab-fnia, 1 mg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J0491
J0491 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, anifrolumab-fnia, 1 mg.
It was added to HCPCS effective 04/01/2022.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Inj anifrolumab-fnia 1mg
- Date added
- 04/01/2022
- Action effective
- 04/01/2022
- BETOS
- O1E
Related J04xx codes
- J0400Injection, aripiprazole, intramuscular, 0.25 mg
- J0401Injection, aripiprazole (abilify maintena), 1 mg
- J0402Injection, aripiprazole (abilify asimtufii), 1 mg
- J0456Injection, azithromycin, 500 mg
- J0457Injection, aztreonam, 100 mg
- J0458Injection, aztreonam/avibactam, 7.5 mg/2.5 mg (10 mg)
- J0461Injection, atropine sulfate, 0.01 mg
- J0462Injection, atropine sulfate, not therapeutically equivalent to j0461, 0.01 mg
- J0463Injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mg
- J0470Injection, dimercaprol, per 100 mg
- J0475Injection, baclofen, 10 mg
- J0476Injection, baclofen, 50 mcg for intrathecal trial
Common questions about J0491
Is HCPCS J0491 still valid?
- Yes. J0491 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J0491?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.